Press release from Companies: CHOSA Oncology AB publishes results from clinical phase 2 trial of liposomal formulation in breast cancer, using predictive marker for cisplatin

Press release from Companies: CHOSA Oncology AB publicerar resultat från klinisk fas 2-studie med liposomal formulering vid bröstcancer, med användning av prediktiv markör för cisplatin

Press release from Companies: Bulletin from the annual general meeting on 26 May 2023 in Chosa Oncology AB

Press release from Companies: Kommuniké från årsstämma den 26 maj 2023 i Chosa Oncology AB

Press release from Companies: CHOSA Oncology AB presents clinical phase 2 results of LiPlaCis and its Drug Response Predictor test at ASCO 2023

Press release from Companies: CHOSA Oncology AB presenterar kliniska fas 2-resultat av LiPlaCis och dess Drug Response Predictor-test vid ASCO 2023

Press release from Companies: CHOSA Oncology AB utlicensierar cancervaccinkandidat i kliniskt stadium till Magle Group

Press release from Companies: CHOSA Oncology AB out-license clinical-stage cancer vaccine candidate to Magle Group

Reports: CHOSA Oncology AB presenterar kvartalsrapport 1 2023

Press release from Companies: CHOSA Oncology AB announces approved re-listing memorandum

Press release from Companies: CHOSA Onocology AB publicerar godkänt åternoteringsmemorandum

Market Notices: Market Notice 98/23 – CHOSA Oncology AB’s share, CHOSA, is transferred to the ordinary list on May 3, 2023